Navigation Links
UCI awarded $27.2 million for new stem cell building
Date:5/7/2008

Irvine, Calif., May 7, 2008 UC Irvine was awarded $27.2 million today from the state to build a new stem cell research facility that will unify and strengthen the campuss fast-growing stem cell biology program and serve as a hub for research in Southern California.

When completed, the three-story, 61,600-square-foot building will house the UCI Sue and Bill Gross Stem Cell Research Center, as many as 26 laboratory-based and clinical researchers, a stem cell techniques course for young scientists, a masters program in biotechnology with an emphasis on stem cell research, and an array of programs and activities that involve and educate patients and the general public.

The new building will be the center of all stem cell activity on campus, said Peter Donovan, co-director of UCIs stem cell center. With a central location, our basic, preclinical and clinical researchers can better work together, share ideas, and take potential therapies from the laboratory to the clinic.

In all, the Independent Citizens Oversight Committee, which governs the California Institute for Regenerative Medicine, awarded $271 million in stem cell research infrastructure funding to 12 institutions statewide. This award brings total CIRM funding to UCI to $46.8 million.

Pending final University of California Board of Regents approval, construction is scheduled to begin in September and finish in July 2010. The facility will be modeled after the existing Hewitt Hall and located within the heart of UCIs Biomedical Research Center in the Health Sciences complex.

The new building will include the core stem cell laboratory and state-of-the-art equipment for human embryonic stem cell line derivation, cell culture, differentiation and purification, and cell and tissue imaging. It also will include clinical space with resources to see patients.

We expect the building will serve not only UCI, but also our regional partners as well as visitors from around the world, said Hans Keirstead, also co-director of the stem cell center.

UCIs stem cell scientists are pioneers in regeneration, in large-scale production of specialized cells with very high purity, and in methods for using such cells to treat damaged tissues.

The first clinical trial in the United States of a human embryonic stem cell-based therapy likely will be based on work performed in Keirsteads lab at UCI. The therapy will treat people with spinal cord injuries, and the trial will be run by Geron Corp.

UCI plans to recruit six faculty members to expand its stem cell research and regenerative medicine programs. Along with other campus resources and support, this commitment is worth approximately $17.5 million over the next 10 years.

I am delighted with the progress our stem cell center directors have made in recruiting and planning for an expanded research program, said Susan Bryant, vice chancellor for research at UCI and a member of the ICOC. Our stem cell program is training young UCI scientists, as well as visiting researchers. We have enormous enthusiasm and excitement about the future of stem cell research at UCI.

In all, the new building will cost approximately $61 million. CIRM funding will be supplemented with private donations and campus debt funding.

Stem cell research promises to transform the treatment of disease and to give us longer, healthier lives, said Edward Thorp, a donor to UCIs stem cell program. Thorp is a founding faculty member at UCI and a pioneer in the field of quantitative finance.

We expect donor support will allow continuing breakthroughs by UCIs stellar research team, Thorp said.

Said Tom Yuen, chairman and chief executive officer of PrimeCell Therapeutics LLC and SRS Labs, and a UCI stem cell program donor: In the next decade, stem cell research will improve our quality of life and expand the frontiers of medicine. At UCI, world-class stem cell scientists and innovators are already setting the winning pace.


'/>"/>

Contact: Jennifer Fitzenberger
jfitzen@uci.edu
949-824-3969
University of California - Irvine
Source:Eurekalert

Related biology news :

1. BIO-key(R) Awarded Mobile Data Contract for Additional 10 Kentucky Law Enforcement Agencies
2. Monell scientist Mark Friedman awarded Guggenheim Fellowship to study diet and obesity
3. Peter J. McGuire, MB BCh, is awarded the 2008-2009 Genzyme/ACMGF Clinical Genetics Fellowship
4. Researchers at Stockholm University awarded the Descartes prize
5. University of Colorado at Boulder awarded $1 million for biofuels research
6. USC awarded $3.9M for lab under the sea
7. Springer author Carlos M. Duarte awarded Spanish science prize
8. 2008 Pew Fellowship in Marine Conservation awarded to Dr. Marie-Joëlle Rochet from IFREMER
9. 2008 Pew Fellowship in Marine Conservation awarded to Fan Meng; first Chinese fellow
10. 2008 Pew Fellowship in Marine Conservation awarded to Dr. Ussif Rashid Sumaila
11. Dr. Andrew Constable awarded 2008 Pew Fellowship in marine conservation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... 2017 The biometrics market has reached ... of organizations, desires to better authenticate or identify ... and challenge questions), biometrics is quickly working its ... market is driven by use cases, though there ... enterprise uses cases, with consumer-facing use cases encompassing ...
(Date:2/6/2017)... , Feb. 6, 2017 According to ... are driving border authorities to continue to embrace ... there are 2143 Automated Border Control (ABC) eGates ... deployed at more than 163 ports of entry ... to 2016 achieving a combined CAGR of 37%. ...
(Date:2/2/2017)... 1, 2017  Central to its deep commitment ... worldwide, The Japan Prize Foundation today announced the ... pushed the envelope in their respective fields of ... scientists are being recognized with the 2017 Japan ... only contribute to the advancement of science and ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... ... ... EIT Digital has launched work to develop a new Smart IOT ... to get under way for the framework, which is designed to reduce the use ... to be transferred eventually to other industries that also require efficient IoT and management ...
(Date:2/16/2017)... , Feb. 16, 2017  MDNA Life ... the development of liquid biopsy tests based on ... into an exclusive license agreement with its first ... proprietary liquid biopsy test for prostate cancer, the ... Korea . This is the first overseas ...
(Date:2/16/2017)... Feb. 16, 2017   Biostage, Inc. (Nasdaq: ... biotechnology company developing bioengineered organ implants to treat cancers ... trachea, announced today the closing on February 15, 2017 ... of common stock and warrants to purchase 20,000,000 shares ... million. The offering was priced at $0.40 per share ...
(Date:2/16/2017)... N.J. , Feb. 16, 2017  Champions Oncology, ... in the development and sale of advanced technology solutions ... oncology drugs, today announced the addition of new cohorts ... These new models will expand Champions, product line ... head and neck cancer, AML, and non-small cell lung ...
Breaking Biology Technology: